申请人:Du Pont Merck Pharmaceutical Company
公开号:US05206249A1
公开(公告)日:1993-04-27
This invention relates to bis-naphthalimides, including 2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]-bis[5-nitro-1H-be nz[de]isoquinoline-1,3(2H)-dione] and 2,2'-[1,2-ethanediylbis[imino(2-methyl-2,1-ethanediyl)]]-bis[5-nitro-1H-be nz[de]isoquinoline-1,3(2H)-dione], processes for their preparation, pharmaceutical compositions containing them, and methods of using them to treat cancer in mammals.
本发明涉及双萘酰亚胺,包括2,2'-[1,2-乙二醇基[亚甲基(1-甲基-2,1-乙二基)]]-双[5-硝基-1H-苯并[de]异喹啉-1,3(2H)-二酮]和2,2'-[1,2-乙二醇基[亚甲基(2-甲基-2,1-乙二基)]]-双[5-硝基-1H-苯并[de]异喹啉-1,3(2H)-二酮],其制备过程,包含它们的制药组合物以及使用它们治疗哺乳动物癌症的方法。